Hanx Biopharmaceuticals set to begin US clinical trial of HX009 in lymphoma

Hanx Biopharmaceuticals (HanxBio) has obtained approval from the US Food and Drug Administration (FDA) for its investigational new drug (IND) of HX009, enabling the company ... Read More